Objective To study on the expression of multiple drug resistance (MDR 1) gene during treatment course of acute leukemia (AL).
目的研究多药耐药(MDR- 1)基因在急性白血病(AL)治疗中的表达。
Objective To investigate the relations between MDR 1 in breast cancer and the ages, stages and lymphatic metastases of the patients.
目的探讨多药耐药基因I (MDR -1)与乳腺癌患者年龄、分期、淋巴结转移等因素的关系。
Results An over expression of immunoreactivities for MDR 1 and MRP was found at both reactive astrocyte and some giant dysplastic neurons, while the overexpression of GFAP co…
结果在手术切除的病灶组织中，除一些增生性的星形胶质细胞同时具上述三种蛋白的阳性标记外，在一些异形的神经元内同时还存在有MDR 1和MRP的阳性表达。
This is equivalent to 1% of the estimated global total of smear-positive cases of MDR-TB.
这相当于痰涂阳性的耐多药结核病例全球估计总数的1%。
Of the US$ 1 billion gap reported by countries for 2012, US$ 200 million is for the MDR-TB response.
各国报告2012年存在的10亿美元资金短缺中，有两亿美元用在耐多药结核病方面。
Purpose:To illustrate anti P gp monoclonal antibody(JSB 1) can reverse multidrug resistance(MDR) of the human kidney cancer.
目的：证实抗P糖蛋白单克隆抗体（JSB1 ）能逆转人肾癌的天然多药耐药（MDR）性。
Through experimental method design and clinical application, this paper investigated the detecting method and clinical significance of multi-drug resistance gene (MDR-1) expression.
本文通过实验方法研究设计和临床应用，探讨肿瘤多药耐药基因（MDR-1）的异常表达检测方法及其临床意义。
The expression of MDR-1 might not contribute to acquired Paclitaxel-resistance in nasopharyngeal carcinoma.
MDR-1在鼻咽癌细胞产生获得性紫杉醇耐药的过程中不起主要作用。
The expression of MDR-1 might not contribute to acquired Paclitaxel-resistance in nasopharyngeal carcinoma.
MDR-1在鼻咽癌细胞产生获得性紫杉醇耐药的过程中不起主要作用。
应用推荐